TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 26)

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.2.1 INCLUSIONS & EXCLUSIONS

1.3 MARKET SCOPE

1.3.1 MARKETS COVERED

1.3.2 YEARS CONSIDERED FOR THE STUDY

1.4 CURRENCY

1.5 LIMITATIONS

1.6 STAKEHOLDERS

1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 30)

2.1 RESEARCH DATA

2.1.1 SECONDARY DATA

2.1.2 PRIMARY DATA

FIGURE 1 BREAKDOWN OF PRIMARIES: IN SITU HYBRIDIZATION MARKET

2.2 MARKET DATA ESTIMATION & TRIANGULATION

FIGURE 2 DATA TRIANGULATION METHODOLOGY

2.3 MARKET ESTIMATION METHODOLOGY

FIGURE 3 MARKET SIZE ESTIMATION (COMPANY REVENUE ANALYSIS-BASED ESTIMATION)

FIGURE 4 IN SITU HYBRIDIZATION MARKET SIZE (USD BILLION)

FIGURE 5 IN SITU HYBRIDIZATION MARKET: FINAL CAGR PROJECTIONS (2020−2025)

FIGURE 6 IN SITU HYBRIDIZATION MARKET: CAGR PROJECTIONS FROM THE ANALYSIS OF DEMAND-SIDE DRIVERS AND OPPORTUNITIES

2.4 INDUSTRY INSIGHTS

2.5 RESEARCH ASSUMPTIONS

3 EXECUTIVE SUMMARY (Page No. - 36)

FIGURE 7 IN SITU HYBRIDIZATION MARKET SHARE, BY PRODUCT, 2019

FIGURE 8 FLUORESCENCE IN SITU HYBRIDIZATION MARKET SHARE, BY TYPE, 2019

FIGURE 9 IN SITU HYBRIDIZATION MARKET, BY END USER: MARKET RANKING OF SEGMENTS, BY MARKET SIZE

FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE IN SITU HYBRIDIZATION MARKET

4 PREMIUM INSIGHTS (Page No. - 39)

4.1 IN SITU HYBRIDIZATION MARKET OVERVIEW

FIGURE 11 RISING FOCUS ON COMPANION DIAGNOSTICS AND INCREASING DISEASE INCIDENCE WILL FAVOR MARKET GROWTH

4.2 ASIA PACIFIC: IN SITU HYBRIDIZATION MARKET SHARE, BY END USER AND COUNTRY (2019)

FIGURE 12 HOSPITAL & DIAGNOSTIC LABORATORIES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2019

4.3 IN SITU HYBRIDIZATION MARKET, BY PRODUCT

FIGURE 13 CONSUMABLES SEGMENT WILL CONTINUE TO DOMINATE THE MARKET

4.4 IN SITU HYBRIDIZATION MARKET SHARE, BY TECHNOLOGY, 2020 VS. 2025

FIGURE 14 FLUORESCENCE IN SITU HYBRIDIZATION HOLDS THE LARGEST SHARE OF THE MARKET, BY TECHNOLOGY

4.5 IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)

FIGURE 15 KITS & REAGENTS SEGMENT ACCOUNT FOR THE LARGEST MARKET SHARE

5 MARKET OVERVIEW (Page No. - 43)

5.1 INTRODUCTION

5.2 MARKET DYNAMICS

FIGURE 16 IN SITU HYBRIDIZATION MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES

5.2.1 MARKET DRIVERS

5.2.1.1 Increasing incidence of genetic disorders and cancer

5.2.1.2 Awareness about companion diagnostics

5.2.2 OPPORTUNITIES

5.2.2.1 Untapped markets in developing countries

5.2.3 CHALLENGES

5.2.3.1 Lack of skilled professionals

5.3 VALUE CHAIN ANALYSIS

FIGURE 17 VALUE CHAIN ANALYSIS OF THE IN SITU HYBRIDIZATION MARKET: RAW MATERIAL AND MANUFACTURING PHASE CONTRIBUTES MAXIMUM VALUE

5.4 IMPACT OF THE COVID-19 OUTBREAK ON THE GROWTH OF THE IN SITU HYBRIDIZATION MARKET

6 IN SITU HYBRIDIZATION MARKET, BY PRODUCT (Page No. - 47)

6.1 INTRODUCTION

TABLE 1 IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

6.2 CONSUMABLES

TABLE 2 IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 3 IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY REGION, 2018�2025 (USD MILLION)

TABLE 4 NORTH AMERICA: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 5 EUROPE: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 6 APAC: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY COUNTRY, 2018�2025 (USD MILLION)

6.2.1 KITS & REAGENTS

6.2.1.1 Increasing focus on companion diagnostics has driven market demand for kits & reagents

TABLE 7 IN SITU HYBRIDIZATION KITS & REAGENTS MARKET, BY REGION, 2018�2025 (USD MILLION)

6.2.2 PROBES

6.2.2.1 Preference for direct localization of DNA/RNA sequences using probes is likely to drive the market

TABLE 8 IN SITU HYBRIDIZATION PROBES MARKET, BY REGION, 2018�2025 (USD MILLION)

6.2.3 ACCESSORIES

TABLE 9 IN SITU HYBRIDIZATION ACCESSORIES MARKET, BY REGION, 2018�2025 (USD MILLION)

6.3 INSTRUMENTS

6.3.1 NEED FOR AUTOMATED SYSTEMS SUPPORTS MARKET GROWTH

TABLE 10 IN SITU HYBRIDIZATION INSTRUMENTS MARKET, BY REGION, 2018�2025 (USD MILLION)

TABLE 11 NORTH AMERICA: IN SITU HYBRIDIZATION INSTRUMENTS MARKET, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 12 EUROPE: IN SITU HYBRIDIZATION INSTRUMENTS MARKET, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 13 APAC: IN SITU HYBRIDIZATION INSTRUMENTS MARKET, BY COUNTRY, 2018�2025 (USD MILLION)

6.4 SOFTWARE

6.4.1 DEMAND FOR SOFTWARE IS DRIVEN BY THE NEED FOR HIGH-SPEED SAMPLE DATA ANALYSIS

TABLE 14 IN SITU HYBRIDIZATION SOFTWARE MARKET, BY REGION, 2018�2025 (USD MILLION)

TABLE 15 NORTH AMERICA: IN SITU HYBRIDIZATION SOFTWARE MARKET, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 16 EUROPE: IN SITU HYBRIDIZATION SOFTWARE MARKET, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 17 APAC: IN SITU HYBRIDIZATION SOFTWARE MARKET, BY COUNTRY, 2018�2025 (USD MILLION)

7 IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY (Page No. - 56)

7.1 INTRODUCTION

TABLE 18 IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018�2025 (USD MILLION)

7.2 FLUORESCENCE IN SITU HYBRIDIZATION

TABLE 19 FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 20 FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY REGION, 2018�2025 (USD MILLION)

TABLE 21 NORTH AMERICA: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 22 EUROPE: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 23 APAC: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018�2025 (USD MILLION)

7.2.1 DNA FLUORESCENCE IN SITU HYBRIDIZATION

7.2.1.1 Need to ensure the stability of genetic material likely to drive the market

TABLE 24 DNA FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY REGION, 2018�2025 (USD MILLION)

TABLE 25 NORTH AMERICA: DNA FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 26 EUROPE: DNA FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 27 APAC: DNA FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018�2025 (USD MILLION)

7.2.2 RNA FLUORESCENCE IN SITU HYBRIDIZATION

7.2.2.1 Rise in biomedical research activity has supported market growth

TABLE 28 RNA FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY REGION, 2018�2025 (USD MILLION)

TABLE 29 NORTH AMERICA: RNA FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 30 EUROPE: RNA FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 31 APAC: RNA FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018�2025 (USD MILLION)

7.2.3 PNA FLUORESCENCE IN SITU HYBRIDIZATION

7.2.3.1 Increased application in infectious disease resulted in market growth

TABLE 32 PNA FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY REGION, 2018�2025 (USD MILLION)

TABLE 33 NORTH AMERICA: PNA FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 34 EUROPE: PNA FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 35 APAC: PNA FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018�2025 (USD MILLION)

7.3 CHROMOGENIC IN SITU HYBRIDIZATION

7.3.1 COST-EFFECTIVENESS OVER FLUORESCENCE IN SITU HYBRIDIZATION FISH SUPPORTS MARKET GROWTH

TABLE 36 CHROMOGENIC IN SITU HYBRIDIZATION MARKET, BY REGION, 2018�2025 (USD MILLION)

TABLE 37 NORTH AMERICA: CHROMOGENIC IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 38 EUROPE: CHROMOGENIC IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 39 APAC: CHROMOGENIC IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018�2025 (USD MILLION)

8 IN SITU HYBRIDIZATION MARKET, BY APPLICATION (Page No. - 66)

8.1 INTRODUCTION

TABLE 40 IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018�2025 (USD MILLION)

8.2 CANCER DIAGNOSTICS

8.2.1 INCREASING IMPORTANCE IN COMPANION DIAGNOSTICS TO DRIVE MARKET GROWTH

TABLE 41 IN SITU HYBRIDIZATION MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2018�2025 (USD MILLION)

TABLE 42 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 43 EUROPE: IN SITU HYBRIDIZATION MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 44 APAC: IN SITU HYBRIDIZATION MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2018�2025 (USD MILLION)

8.3 CYTOLOGY

8.3.1 FISH IS PREFERRED IN THE DETECTION OF CHROMOSOMAL ABNORMALITIES

TABLE 45 IN SITU HYBRIDIZATION MARKET FOR CYTOLOGY, BY REGION, 2018�2025 (USD MILLION)

TABLE 46 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET FOR CYTOLOGY, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 47 EUROPE: IN SITU HYBRIDIZATION MARKET FOR CYTOLOGY, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 48 APAC: IN SITU HYBRIDIZATION MARKET FOR CYTOLOGY, BY COUNTRY, 2018�2025 (USD MILLION)

8.4 INFECTIOUS DISEASE DIAGNOSTICS

8.4.1 NEED FOR HIGH SENSITIVITY AND SPECIFICITY IN INFECTIOUS DIAGNOSIS IS LIKELY TO SUPPORT MARKET GROWTH

TABLE 49 IN SITU HYBRIDIZATION MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018�2025 (USD MILLION)

TABLE 50 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 51 EUROPE: IN SITU HYBRIDIZATION MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 52 APAC: IN SITU HYBRIDIZATION MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2018�2025 (USD MILLION)

8.5 NEUROSCIENCE

8.5.1 RISING BURDEN OF NEUROLOGICAL DISORDERS HAS BOOSTED OVERALL R&D ACTIVITY

TABLE 53 IN SITU HYBRIDIZATION MARKET FOR NEUROSCIENCE, BY REGION, 2018�2025 (USD MILLION)

TABLE 54 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET FOR NEUROSCIENCE, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 55 EUROPE: IN SITU HYBRIDIZATION MARKET FOR NEUROSCIENCE, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 56 APAC: IN SITU HYBRIDIZATION MARKET FOR NEUROSCIENCE, BY COUNTRY, 2018�2025 (USD MILLION)

8.6 IMMUNOLOGY

8.6.1 RISING INCIDENCE OF AUTOIMMUNE DISEASES SUPPORTS MARKET GROWTH

TABLE 57 IN SITU HYBRIDIZATION MARKET FOR IMMUNOLOGY, BY REGION, 2018�2025 (USD MILLION)

TABLE 58 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET FOR IMMUNOLOGY, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 59 EUROPE: IN SITU HYBRIDIZATION MARKET FOR IMMUNOLOGY, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 60 APAC: IN SITU HYBRIDIZATION MARKET FOR IMMUNOLOGY, BY COUNTRY, 2018�2025 (USD MILLION)

9 IN SITU HYBRIDIZATION MARKET, BY END USER (Page No. - 76)

9.1 INTRODUCTION

TABLE 61 IN SITU HYBRIDIZATION MARKET, BY END USER, 2018�2025 (USD MILLION)

9.2 HOSPITAL & DIAGNOSTIC LABORATORIES

9.2.1 DEMAND FOR MOLECULAR TESTS TO DRIVE MARKET GROWTH

TABLE 62 IN SITU HYBRIDIZATION MARKET FOR HOSPITAL & DIAGNOSTIC LABORATORIES, BY REGION, 2018�2025 (USD MILLION)

TABLE 63 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET FOR HOSPITAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 64 EUROPE: IN SITU HYBRIDIZATION MARKET FOR HOSPITAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 65 APAC: IN SITU HYBRIDIZATION MARKET FOR HOSPITAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018�2025 (USD MILLION)

9.3 ACADEMIC & RESEARCH INSTITUTES

9.3.1 INCREASING RESEARCH ON CHROMOSOMAL ABNORMALITIES WILL SUPPORT MARKET GROWTH

TABLE 66 IN SITU HYBRIDIZATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018�2025 (USD MILLION)

TABLE 67 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 68 EUROPE: IN SITU HYBRIDIZATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 69 APAC: IN SITU HYBRIDIZATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018�2025 (USD MILLION)

9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

9.4.1 NEED TO DEVELOP PRECISION TREATMENTS DRIVES DEMAND FOR IN SITU HYBRIDIZATION

TABLE 70 IN SITU HYBRIDIZATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018�2025 (USD MILLION)

TABLE 71 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 72 EUROPE: IN SITU HYBRIDIZATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 73 APAC: IN SITU HYBRIDIZATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018�2025 (USD MILLION)

9.5 CONTRACT RESEARCH ORGANIZATIONS

9.5.1 INCREASING OUTSOURCING OF RESEARCH ACTIVITIES TO SUPPORT MARKET GROWTH

TABLE 74 IN SITU HYBRIDIZATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018�2025 (USD MILLION)

TABLE 75 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 76 EUROPE: IN SITU HYBRIDIZATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 77 APAC: IN SITU HYBRIDIZATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018�2025 (USD MILLION)

10 IN SITU HYBRIDIZATION MARKET, BY REGION (Page No. - 85)

10.1 INTRODUCTION

FIGURE 18 IN SITU HYBRIDIZATION MARKET SNAPSHOT

TABLE 78 IN SITU HYBRIDIZATION MARKET, BY REGION, 2018�2025 (USD MILLION)

10.2 NORTH AMERICA

FIGURE 19 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET SNAPSHOT

TABLE 79 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 80 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018�2025 (USD MILLION)

TABLE 81 NORTH AMERICA: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 82 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 83 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 84 NORTH AMERICA: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018�2025(USD MILLION)

TABLE 85 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018�2025 (USD MILLION)

10.2.1 US

10.2.1.1 Government funding for life science research drives the market growth in the US

TABLE 86 US: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018�2025 (USD MILLION)

TABLE 87 US: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 88 US: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 89 US: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 90 US: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 91 US: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018�2025 (USD MILLION)

10.2.2 CANADA

10.2.2.1 Investments by the Canadian government and non-profit organizations for innovation are likely to boost the market

TABLE 92 CANADA: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018�2025 (USD MILLION)

TABLE 93 CANADA: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 94 CANADA: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 95 CANADA: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 96 CANADA: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 97 CANADA: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018�2025 (USD MILLION)

10.3 EUROPE

TABLE 98 EUROPE: IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 99 EUROPE: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018�2025 (USD MILLION)

TABLE 100 EUROPE: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 101 EUROPE: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 102 EUROPE: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 103 EUROPE: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 104 EUROPE: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018�2025 (USD MILLION)

10.3.1 GERMANY

10.3.1.1 Germany accounted for the largest share of the European market

TABLE 105 GERMANY: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018�2025 (USD MILLION)

TABLE 106 GERMANY: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 107 GERMANY: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 108 GERMANY: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 109 GERMANY: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 110 GERMANY: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018�2025 (USD MILLION)

10.3.2 FRANCE

10.3.2.1 Increased investments in proteomics and genomics are likely to fuel the growth of ISH technology

TABLE 111 FRANCE: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018�2025 (USD MILLION)

TABLE 112 FRANCE: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 113 FRANCE: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 114 FRANCE: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 115 FRANCE: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 116 FRANCE: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018�2025 (USD MILLION)

10.3.3 UK

10.3.3.1 Increasing focus on cancer research in the UK is a key market growth driver

TABLE 117 UK: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018�2025 (USD MILLION)

TABLE 118 UK: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 119 UK: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 120 UK: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 121 UK: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 122 UK: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018�2025 (USD MILLION)

10.3.4 REST OF EUROPE

TABLE 123 ROE: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018�2025 (USD MILLION)

TABLE 124 ROE: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 125 ROE: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 126 ROE: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 127 ROE: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 128 ROE: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018�2025 (USD MILLION)

10.4 ASIA PACIFIC

FIGURE 20 ASIA PACIFIC: IN SITU HYBRIDIZATION MARKET SNAPSHOT

TABLE 129 APAC: IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 130 APAC: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018�2025 (USD MILLION)

TABLE 131 APAC: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 132 APAC: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 133 APAC: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 134 APAC: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 135 APAC: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018�2025 (USD MILLION)

10.4.1 JAPAN

10.4.1.1 Focus on personalized diagnostics products to support market growth in Japan

TABLE 136 JAPAN: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018�2025 (USD MILLION)

TABLE 137 JAPAN: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 138 JAPAN: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 139 JAPAN: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 140 JAPAN: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 141 JAPAN: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018�2025 (USD MILLION)

10.4.2 CHINA

10.4.2.1 China forms the fastest-growing market in the APAC

TABLE 142 CHINA: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018�2025 (USD MILLION)

TABLE 143 CHINA: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 144 CHINA: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 145 CHINA: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 146 CHINA: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 147 CHINA: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018�2025 (USD MILLION)

10.4.3 INDIA

10.4.3.1 Collaborations between hospitals and diagnostics labs will propel market growth in India

TABLE 148 INDIA: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018�2025 (USD MILLION)

TABLE 149 INDIA: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 150 INDIA: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 151 INDIA: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 152 INDIA: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 153 INDIA: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018�2025 (USD MILLION)

10.4.4 REST OF ASIA PACIFIC

TABLE 154 ROAPAC: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018�2025 (USD MILLION)

TABLE 155 ROAPAC: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 156 ROAPAC: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 157 ROAPAC: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 158 ROAPAC: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 159 ROAPAC: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018�2025 (USD MILLION)

10.5 REST OF THE WORLD

TABLE 160 ROW: IN SITU HYBRIDIZATION MARKET, BY REGION, 2018�2025 (USD MILLION)

TABLE 161 ROW: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018�2025 (USD MILLION)

TABLE 162 ROW: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 163 ROW: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 164 ROW: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 165 ROW: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 166 ROW: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018�2025 (USD MILLION)

10.5.1 LATIN AMERICA

10.5.1.1 Growing cancer screening programs will propel market growth in Latin America

TABLE 167 LATAM: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018�2025 (USD MILLION)

TABLE 168 LATAM: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 169 LATAM: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 170 LATAM: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 171 LATAM: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 172 LATAM: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018�2025 (USD MILLION)

10.5.2 MIDDLE EAST & AFRICA

10.5.2.1 Infrastructural development is expected to contribute to the growth of the MEA market

TABLE 173 MEA: IN SITU HYBRIDIZATION MARKET, BY TECHNOLOGY, 2018�2025 (USD MILLION)

TABLE 174 MEA: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 175 MEA: IN SITU HYBRIDIZATION MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 176 MEA: IN SITU HYBRIDIZATION MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 177 MEA: IN SITU HYBRIDIZATION CONSUMABLES MARKET, BY TYPE, 2018�2025 (USD MILLION)

TABLE 178 MEA: IN SITU HYBRIDIZATION MARKET, BY APPLICATION, 2018�2025 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 126)

11.1 INTRODUCTION

11.2 MARKET RANKING ANALYSIS

FIGURE 21 COMPANY RANKING IN THE IN SITU HYBRIDIZATION MARKET, 2019

11.3 MARKET EVALUATION FRAMEWORK

TABLE 179 MARKET EVALUATION FRAMEWORK: AGREEMENT & PRODUCT LAUNCH�THE MAJOR STRATEGY ADOPTED BY PLAYERS

11.4 COMPETITIVE SCENARIO

11.4.1 KEY PRODUCT LAUNCHES

11.4.2 KEY COLLABORATIONS & AGREEMENTS

11.4.3 KEY EXPANSIONS

12 COMPANY EVALUATION MATRIX AND COMPANY PROFILES (Page No. - 128)

12.1 OVERVIEW

12.2 IN SITU HYBRIDIZATION MARKET: COMPANY EVALUATION MATRIX

12.2.1 STARS

12.2.2 EMERGING LEADERS

12.2.3 PERVASIVE COMPANIES

12.2.4 EMERGING COMPANIES

FIGURE 22 GLOBAL IN SITU HYBRIDIZATION MARKET: COMPANY EVALUATION MATRIX, 2019

12.3 COMPANY PROFILES

12.3.1 ABBOTT LABORATORIES

FIGURE 23 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)

12.3.2 F. HOFFMANN-LA ROCHE

FIGURE 24 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2019)

12.3.3 AGILENT TECHNOLOGIES

FIGURE 25 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2019)

12.3.4 THERMO FISHER SCIENTIFIC

FIGURE 26 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019)

12.3.5 BIO-TECHNE CORPORATION

FIGURE 27 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2019)

12.3.6 QIAGEN N.V.

FIGURE 28 QIAGEN N.V.: COMPANY SNAPSHOT (2019)

12.3.7 DANAHER CORPORATION

FIGURE 29 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)

12.3.8 PERKINELMER

FIGURE 30 PERKINELMER: COMPANY SNAPSHOT (2019)

12.3.9 ENZO BIOCHEM

FIGURE 31 ENZO BIOCHEM: COMPANY SNAPSHOT (2019)

12.3.10 BIO-RAD LABORATORIES

FIGURE 32 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2019)

12.3.11 MERCK KGAA

FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2019)

12.3.12 ABNOVA CORPORATION

12.3.13 BIOGENEX LABORATORIES

12.3.14 BIOCARE MEDICAL

12.3.15 OPGEN

FIGURE 34 OPGEN: COMPANY SNAPSHOT (2019)

12.3.16 BIO SB

12.3.17 GENEMED BIOTECHNOLOGIES

12.3.18 ABCAM

FIGURE 35 ABCAM: COMPANY SNAPSHOT (2019)

12.3.19 CREATIVE BIOARRAY

12.3.20 BIOCAT GMBH

12.3.21 ZYTOVISION

13 APPENDIX (Page No. - 163)

13.1 DISCUSSION GUIDE

13.2 KNOWLEDGE STORE: MARKETSANDMARKETS� SUBSCRIPTION PORTAL

13.3 AVAILABLE CUSTOMIZATIONS

13.4 RELATED REPORTS

13.5 AUTHOR DETAILS